Given the observed negative association between α-Klotho and both CVD risk and cardiometabolic comorbidities, we conducted mediation analyses to explore whether metabolic conditions—T2DM, obesity, CKD, and NAFLD—serve as intermediaries in this relationship. Here, KL is linked to chronic kidney disease.